Auxiliary Partial Orthotopic Liver Transplantation with De Novo Autoimmune Hepatitis in the Allograft and Leftover Primary Biliary Cirrhosis in the Native Liver

Hirokazu Tsuji; Katsushi Hiramatsu; Hiroshi Minato; Shuichi Kaneko; Yasuni Nakanuma

doi:10.1055/s-2005-916328

Seminars in Liver Disease, Inhaltsverzeichnis

Semin Liver Dis 2005; 25(3): 371-377
DOI: 10.1055/s-2005-916328

DIAGNOSTIC PROBLEMS IN HEPATOLOGY

Auxiliary Partial Orthotopic Liver Transplantation with De Novo Autoimmune Hepatitis in the Allograft and Leftover Primary Biliary Cirrhosis in the Native Liver

Hirokazu Tsuji¹ , Katsushi Hiramatsu¹ ^, ² , Hiroshi Minato³ , Shuichi Kaneko¹ , Yasuni Nakanuma²

¹Department of Gastroenterology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
²Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
³Department of Diagnostic Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan

Abstract

Volltext

Referenzen

REFERENCES

1 Portmann B C, Nakanuma Y. Diseases of bile ducts. In: MacSween RNM, Burt AD, Portmann BC, et al Pathology of the Liver, 4th ed. London; Churchill Livingstone 2001: 435-506
2 Nakanuma Y, Saito K, Unoura M. Semiquantitative assessment of cholestasis and lymphocytic piecemeal necrosis in primary biliary cirrhosis: a histologic and immunohistochemical study. J Clin Gastroenterol. 1990; 12 357-362
3 Sakahara H, Kiuchi T, Nishizawa S et al.. Asialoglycoprotein receptor scintigraphy in evaluation of auxiliary partial orthotopic liver transplantation. J Nucl Med. 1999; 40 1463-1467
4 Demetris A, Adams D, Bellamy C et al.. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000; 31 792-799
5 Wiesner R H, Demetris A J, Belle S H et al.. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology. 1998; 28 638-645
6 D'Antiga L, Dhawan A, Portmann B et al.. Late cellular rejection in paediatric liver transplantation: aetiology and outcome. Transplantation. 2002; 73 80-84
7 Riely C A, Vera S R. Liver biopsy in the long-term follow-up of liver transplant patients: still the gold standard. Gastroenterology. 1990; 99 1182-1183
8 Snover D C, Sibley R K, Freese D K et al.. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology. 1984; 4 1212-1222
9 Anonymous. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997; 25 658-663
10 International Working Party . Terminology for hepatic allograft rejection. Hepatology. 1995; 22 648-654
11 Ludwig J. Terminology of hepatic allograft rejection (glossary). Semin Liver Dis. 1992; 12 89-92
12 Neuberger J. Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. Liver Transpl Surg. 1995; 1 109-115
13 Aguilera I, Sousa J M, Gavilan F et al.. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl. 2004; 10 1166-1172
14 Kerkar N, Hadzic N, Davies E T et al.. De-novo autoimmune hepatitis after liver transplantation. Lancet. 1998; 351 409-413
15 Jones D E, James O F, Portmann B et al.. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology. 1999; 30 53-57
16 Gupta P, Hart J, Millis J M et al.. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation. 2001; 71 664-668
17 Heneghan M A, Portmann B C, Norris S M et al.. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology. 2001; 34 464-470
18 Salcedo M, Vaquero J, Banares R et al.. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology. 2002; 35 349-356
19 Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol. 2004; 40 3-7
20 Nalesnik M A, Jaffe R, Starzl T E et al.. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988; 133 173-192
21 Klintmalm G B, Iwatsuki S, Starzl T E. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation. 1981; 32 488-489
22 Alvarez F, Berg P A, Bianchi F B et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31 929-938
23 Salcedo M, Vaquero J, Banares R et al.. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology. 2002; 35 349-356
24 Heathcote E J. Primary Biliary Cirrhosis. In: Schiff ER, Sorrell MF, Maddrey WC Schiff's Disease of the Liver, Vol. 1. Philadelphia, PA; Lippincott-Williams & Wilkins 2003: 701-712
25 Hashimoto E, Shimada M, Noguchi S et al.. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl. 2001; 7 588-595
26 Hubscher S G, Elias E, Buckels J A et al.. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol. 1993; 18 173-184
27 Balan V, Batts K P, Porayko M K et al.. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology. 1993; 18 1392-1398
28 Khettry U, Anand N, Faul P N et al.. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study. Liver Transpl. 2003; 9 87-96
29 Tan C K, Sian Ho J M. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation. Liver Transpl. 2001; 7 461-465
30 Czaja A J. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl. 2002; 8 505-513
31 Dubel L, Farges O, Johanet C et al.. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation. 1998; 65 1072-1075
32 Dunn M J, Rose M L, Latif N et al.. Demonstration by western blotting of antiheart antibodies before and after cardiac transplantation. Transplantation. 1991; 51 806-812
33 Joyce S, Mathew J M, Flye M W, Mohanakumar T. A polymorphic human kidney-specific non-MHC alloantigen. Its possible role in tissue-specific allograft immunity. Transplantation. 1992; 53 1119-1127
34 Aguilera I, Wichmann I, Sousa J M et al.. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol. 2001; 126 535-539
35 Miyagawa-Hayashino A, Haga H, Sakurai T et al.. De novo autoimmune hepatitis affecting allograft but not the native liver in auxiliary partial orthotopic liver transplantation. Transplantation. 2003; 76 271-272

Yasuni NakanumaM.D.

Professor of Pathology, Department of Human Pathology, Kanazawa University Graduate School of Medicine

Kanazawa 920-8640, Japan